nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.11.2011 | Original Paper

OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer

verfasst von: Zuyan Luo, Qi Zhang, Zhongsheng Zhao, Bo Li, Junfa Chen, Yuanyu Wang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The present study investigated the clinical significance of the relationship between olfactomedin 4 (OLFM4) expression and the clinicopathological features of patients with gastric cancer.

Methods

Tumor tissue and adjacent normal tissue, lymph nodes, and peritoneal metastases were analyzed by the Affymetrix GeneChip^® HG-U133A2.0 array. The expression of OLFM4 was detected by real-time quantitative RT-PCR in gastric tumor tissue and adjacent normal tissue. OLFM4 expression was analyzed by immunohistochemistry in 436 clinicopathologically characterized gastric cancer cases and in corresponding distant metastases from 61 patients.

Results

A total of 434 genes and 169 expressed sequence tags were upregulated, including OLFM4. The expression of OLFM4 mRNA or protein differed significantly among gastric tumor tissue, matched normal gastric mucosa, and lymph node metastases. Further multivariate analysis suggested that lymph node metastases and distant metastases, TNM stage, and expression of OLFM4 were independent prognostic indicators for gastric cancer.

Conclusion

Gene expression profiles were useful for simultaneously analyzing the expression levels of thousands of genes. Reduced expression of OLFM4 in gastric cancer is associated significantly with lymph node and distant metastases and with poor prognosis. OLFM4 may prove to be an important molecular marker for predicting the carcinogenesis, development, progression, and metastasis of gastric cancer.

Aung PP, Oue N, Mitani Y et al (2006) Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 25(17):2546–2557PubMedCrossRef

Chin KL, Aerbajinai W, Zhu J et al (2008) The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor. Br J Haematol 143(3):421–432PubMedCrossRef

Grutzmann R, Pilarsky C, Staub E et al (2003) Systematic isolation of genes differentially expressed in normal and cancerous tissue of the pancreas. Pancreatology 3(2):169–178PubMedCrossRef

Huang Y, Yang M, Yang H et al (2010) Upregulation of the GRIM-19 gene suppresses invasion and metastasis of human gastric cancer SGC-7901 cell line. Exp Cell Res 316(13):2061–2070PubMedCrossRef

Kobayashi D, Koshida S, Moriai R et al (2007) Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells. Cancer Sci 98(3):334–340PubMedCrossRef

Koshida S, Kobayashi D, Moriai R et al (2007) Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Sci 98(3):315–320PubMedCrossRef

Kulkarni NH, Karavanich CA, Atchley WR et al (2000) Characterization and differential expression of a human gene family of olfactomedin-related proteins. Genet Res 76(1):41–50PubMedCrossRef

Liu W, Chen L, Zhu J et al (2006) The glycoprotein hGC-1 binds to cadherin and lectins. Exp Cell Res 312(10):1785–1797PubMedCrossRef

Liu W, Zhu J, Cao L et al (2007) Expression of hGC-1 is correlated with differentiation of gastric carcinoma. Histopathology 51(2):157–165PubMedCrossRef

Liu W, Liu Y, Zhu J et al (2008) Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma. Clin Cancer Res 14(4):1041–1049PubMedCrossRef

Mannick EE, Schurr JR, Zapata A et al (2004) Gene expression in gastric biopsies from patients infected with Helicobacter pylori. Scand J Gastroenterol 39(12):1192–1200PubMedCrossRef

Moreno TA, Bronner-Fraser M (2001) The secreted glycoprotein Noelin-1 promotes neurogenesis in Xenopus. Dev Biol 240(2):340–360PubMedCrossRef

Nguyen TD, Chen P, Huang WD et al (1998) Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem 273(11):6341–6350PubMedCrossRef

Ortego J, Escribano J, Coca-Prados M (1997) Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin. FEBS Lett 413(2):349–353PubMedCrossRef

Oue N, Aung PP, Mitani Y et al (2005) Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 69(Suppl 1):17–22PubMedCrossRef

Oue N, Sentani K, Noguchi T et al (2009) Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 125(10):2383–2392PubMedCrossRef

Shinozaki S, Nakamura T, Iimura M et al (2001) Upregulation of Reg 1 alpha and GW112 in the epithelium of inflamed colonic mucosa. Gut 48(5):623–629PubMedCrossRef

Wang YY, Ye ZY, Zhao ZS et al (2010) High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann Surg Oncol 17(1):89–97PubMedCrossRef

Wentzensen N, Wilz B, Findeisen P et al (2004) Identification of differentially expressed genes in colorectal adenoma compared to normal tissue by suppression subtractive hybridization. Int J Oncol 24(4):987–994PubMed

Yang RB, Au HK, Tzeng CR et al (2010) Characterization of a novel cell-surface protein expressed on human sperm. Hum Reprod 25(1):42–51PubMedCrossRef

Yasui W, Oue N, Aung PP et al (2005) Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 8(2):86–94PubMedCrossRef

Yokoe H, Anholt RR (1993) Molecular cloning of olfactomedin, an extracellular matrix protein specific to olfactory neuroepithelium. Proc Natl Acad Sci 90(10):4655–4659PubMedCrossRef

Zeng LC, Han ZG, Ma WJ (2005) Elucidation of subfamily segregation and intramolecular coevolution of the olfactomedin-like proteins by comprehensive phylogenetic analysis and gene expression pattern assessment. FEBS Lett 579(25):5443–5453PubMedCrossRef

Zhang J, Liu WL, Tang DC et al (2002) Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development. Gene 283(1–2):83–93PubMedCrossRef

Zhang X, Huang Q, Yang Z et al (2004) GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Res 64(7):2474–2481PubMedCrossRef

Zhao ZS, Wang YY, Ye ZY et al (2009) Prognostic value of tumor-related molecular expression in gastric carcinoma. Pathol Oncol Res 15(4):589–596PubMedCrossRef

Zhao ZS, Wang YY, Chu YQ et al (2010a) SPARC is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 16(1):260–268PubMedCrossRef

Zhao ZS, Chu YQ, Ye ZY et al (2010b) Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance. Hum Pathol 41(5):686–696PubMedCrossRef

Zheng L, Wang L, Ajani J et al (2004) Molecular basis of gastric cancer development and progression. Gastric Cancer 7(2):61–77PubMedCrossRef

Titel: OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer
verfasst von: Zuyan Luo
Qi Zhang
Zhongsheng Zhao
Bo Li
Junfa Chen
Yuanyu Wang
Publikationsdatum: 01.11.2011
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2011
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-011-1042-9

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2011

Redox regulation of cytokeratin 18 protein by NADPH oxidase 1 in preneoplastic human epithelial cells

Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial–mesenchymal transition in gastric cancers

PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer

Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis

Characteristics of aggressive variants in T1a renal cell carcinoma

Microelectromechanical system-based diagnostic technology for cervical cancer

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie